Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP055473
下载链接
链接失效反馈官方服务：
资源简介：
These are tumor biopsies and corresponding normal samples from patients with early stage ER+/HER2- breast cancer who had received the aromatase inhibitor letrozole for 10-21 days prior to surgery.
创建时间：
2017-09-17
